Potential of nutraceutical products for irritable bowel syndrome remission maintenance

Potential of nutraceutical products for irritable bowel syndrome remission maintenance

Aim of review. To summarize the modern data on pathogenesis of symptoms irritable bowel syndrome (IBS) symptoms, to present nutraceutical product «Standart zdorovya: GASTRO» as an agent for IBS remission maintenance. Summary. Recent data indicate essential changes of intestinal microbiota in IBS in...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. I. Ulyanin, Ye. A. Poluektova, Ch. S. Pavlov, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	синдром раздраженного кишечника нутрицевтические продукты микробиота ремиссия
Online Access:	https://www.gastro-j.ru/jour/article/view/233
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-term results of irritable bowel syndrome treatment
by: A. I. Ulyanin, et al.
Published: (2018-08-01)

Comparative of relation of American, German, French and Russian guidelines on irritable bowel syndrome management
by: Arkady A. Sheptulin, et al.
Published: (2016-08-01)

Irritable bowel syndrome concept from the gut microbiom point of view
by: Anna F. Sheptulina, et al.
Published: (2018-08-01)

Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Dysphoric spectrum of emotional disorders at irritable bowel syndrome
by: M. A. Morozova, et al.
Published: (2018-08-01)

Review of Rome-IV criteria for the irritable bowel syndrome: are there any basic changes?
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Diet with decreased content of fermentable oligo-, diand monosaccharides and polyols (low FODMAP-diet) in treatment of irritable bowel syndrome
by: I. L. Khalif, et al.
Published: (2018-08-01)

Patterns of colonic dismotility and visceral hypersensitivity at various clinical variants of irritable bowel syndrome
by: Ekaterina A. Bubnova, et al.
Published: (2018-08-01)

Evaluation of the functional gastrointestinal diseases concept from standpoints of Rome IV (2016) diagnostic criteria (review)
by: D. N. Andreyev, et al.
Published: (2018-08-01)

Возможности применения Опросника «7х7» (7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Treatment compliance of patients with gastro-intestinal diseases
by: O. P. Alekseyeva, et al.
Published: (2016-08-01)

Short bowel syndrome: pathogenesis, clinical presentation and treatment
by: Anna F. Sheptulina, et al.
Published: (2016-08-01)

Modern methods of studying of human gastro-intestinal microflora
by: Ye. A. Poluektova, et al.
Published: (2014-08-01)

Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

INTESTINAL MICROBIOME - A LEADING FACTOR IN HUMAN HEALTH AND DISEASES
by: E. Blum Hubert
Published: (2018-08-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Treatment of autonomous intestinal neuropathy in critical care by prucalopride and multistrain probiotic
by: A. L. Kovaleva, et al.
Published: (2018-08-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

Noninvasive markers of inflammatory bowel disease activity
by: A. V. Nikitin, et al.
Published: (2018-08-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

Effect of antisecretory treatment on gastrointestinal microbiota
by: D. Ye. Rumyantseva, et al.
Published: (2018-08-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Nutraceuticals and Pharmaceuticals
by: E. A. Poluektova, et al.
Published: (2020-05-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

The Effectiveness of Add-on Treatment with Nutraceutical
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

Clinical guidelines for the diagnosis and treatment of patients with irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2014-08-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)
by: V. T. Ivashkin, et al.
Published: (2022-08-01)